Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

Journal Article (Journal Article)

BACKGROUND: Observational studies suggest greater height is associated with increased ovarian cancer risk, but cannot exclude bias and/or confounding as explanations for this. Mendelian randomisation (MR) can provide evidence which may be less prone to bias. METHODS: We pooled data from 39 Ovarian Cancer Association Consortium studies (16,395 cases; 23,003 controls). We applied two-stage predictor-substitution MR, using a weighted genetic risk score combining 609 single-nucleotide polymorphisms. Study-specific odds ratios (OR) and 95% confidence intervals (CI) for the association between genetically predicted height and risk were pooled using random-effects meta-analysis. RESULTS: Greater genetically predicted height was associated with increased ovarian cancer risk overall (pooled-OR (pOR) = 1.06; 95% CI: 1.01-1.11 per 5 cm increase in height), and separately for invasive (pOR = 1.06; 95% CI: 1.01-1.11) and borderline (pOR = 1.15; 95% CI: 1.02-1.29) tumours. CONCLUSIONS: Women with a genetic propensity to being taller have increased risk of ovarian cancer. This suggests genes influencing height are involved in pathways promoting ovarian carcinogenesis.

Full Text

Duke Authors

Cited Authors

  • Dixon-Suen, SC; Nagle, CM; Thrift, AP; Pharoah, PDP; Ewing, A; Pearce, CL; Zheng, W; Australian Ovarian Cancer Study Group, ; Chenevix-Trench, G; Fasching, PA; Beckmann, MW; Lambrechts, D; Vergote, I; Lambrechts, S; Van Nieuwenhuysen, E; Rossing, MA; Doherty, JA; Wicklund, KG; Chang-Claude, J; Jung, AY; Moysich, KB; Odunsi, K; Goodman, MT; Wilkens, LR; Thompson, PJ; Shvetsov, YB; Dörk, T; Park-Simon, T-W; Hillemanns, P; Bogdanova, N; Butzow, R; Nevanlinna, H; Pelttari, LM; Leminen, A; Modugno, F; Ness, RB; Edwards, RP; Kelley, JL; Heitz, F; du Bois, A; Harter, P; Schwaab, I; Karlan, BY; Lester, J; Orsulic, S; Rimel, BJ; Kjær, SK; Høgdall, E; Jensen, A; Goode, EL; Fridley, BL; Cunningham, JM; Winham, SJ; Giles, GG; Bruinsma, F; Milne, RL; Southey, MC; Hildebrandt, MAT; Wu, X; Lu, KH; Liang, D; Levine, DA; Bisogna, M; Schildkraut, JM; Berchuck, A; Cramer, DW; Terry, KL; Bandera, EV; Olson, SH; Salvesen, HB; Thomsen, LCV; Kopperud, RK; Bjorge, L; Kiemeney, LA; Massuger, LFAG; Pejovic, T; Bruegl, A; Cook, LS; Le, ND; Swenerton, KD; Brooks-Wilson, A; Kelemen, LE; LubiƄski, J; Huzarski, T; Gronwald, J; Menkiszak, J; Wentzensen, N; Brinton, L; Yang, H; Lissowska, J; Høgdall, CK; Lundvall, L; Song, H; Tyrer, JP; Campbell, I; Eccles, D; Paul, J; Glasspool, R; Siddiqui, N; Whittemore, AS; Sieh, W; McGuire, V; Rothstein, JH; Narod, SA; Phelan, C; Risch, HA; McLaughlin, JR; Anton-Culver, H; Ziogas, A; Menon, U; Gayther, SA; Ramus, SJ; Gentry-Maharaj, A; Wu, AH; Pike, MC; Tseng, C-C; Kupryjanczyk, J; Dansonka-Mieszkowska, A; Budzilowska, A; Rzepecka, IK; Webb, PM; Ovarian Cancer Association Consortium,

Published Date

  • April 2018

Published In

Volume / Issue

  • 118 / 8

Start / End Page

  • 1123 - 1129

PubMed ID

  • 29555990

Pubmed Central ID

  • 29555990

Electronic International Standard Serial Number (EISSN)

  • 1532-1827

Digital Object Identifier (DOI)

  • 10.1038/s41416-018-0011-3

Language

  • eng

Conference Location

  • England